Atlas Trials

Study of Quality of Life and Hormone Levels in Premenopausal Participants With Early Breast Cancer Receiving Triptorelin Plus Additional Cancer Treatment

Clinical trial NCT05377684 · COMPLETED

Trial details

NCT number
NCT05377684
Sponsor
Ipsen
Status
COMPLETED
Study type
OBSERVATIONAL
Early-stage Breast Cancer
Start date
2022-06-09
Primary completion
2026-06-04
Enrollment
450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.